Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/19/1997EP0806935A2 Anti-adhesive active principles
11/19/1997EP0806933A1 Formulations and methods for reducing skin irritation
11/19/1997EP0806894A1 Micellar nanoparticles
11/19/1997EP0765658B1 Use of salicylic acid derivatives for the treatment of striae
11/19/1997EP0754188B1 Oligonucleotides with anti-cytomegalovirus activity
11/19/1997EP0731807A4 N-2 substituted purines
11/19/1997EP0720604B1 Conformationally locked nucleoside analogues
11/19/1997EP0714418A4 Cosmetic melanins
11/19/1997EP0682657B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE
11/19/1997EP0679157B1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/19/1997EP0598093B1 Quinuclidine derivatives as squalene synthetase inhibitors
11/19/1997EP0566567B1 Antihypertensive benzopyran derivatives
11/19/1997EP0536177B1 Thrombin inhibitors based on the amino acid sequence of hirudin
11/19/1997EP0257102B1 Agents for treating neurophathy
11/19/1997CN1165520A Phenylsubstituted 4-azasteroid fluoroderivatives
11/19/1997CN1165510A Amine derivatives
11/19/1997CN1165483A Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
11/19/1997CN1165482A Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
11/19/1997CN1165481A Method and compositions for inhibiting protein kinases
11/19/1997CN1165480A Liposome-formulation for treatment of viral diseases
11/19/1997CN1165477A Delivery of solid drug compositions
11/19/1997CN1165471A Antiparasitic composition for treating and protecting pets
11/19/1997CN1165035A Antigen-antibody-recombination DNA composite type vaccin
11/19/1997CN1165021A Medicine composition for treatment of tracheitis and asthma
11/19/1997CN1165013A 微涂灵软膏 Micro-painted Ointment
11/19/1997CN1165000A Method of reducing tissue damage associated with ischemia
11/19/1997CN1164999A Benzopyran derivative and use of said benzopyran derivative for treating heart disease
11/18/1997US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997US5688990 Forming chemical intermediates for azetidinone compounds that inhibit cholesterol biosynthesis for prevention of atherosclerosis
11/18/1997US5688981 Ethylenediaminetriacetic acid and N-acyl ethylenediaminetriacetic acid silver chelating agents and surfactants
11/18/1997US5688968 Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno 2,3-B!thiopyran-2-sulfonamide 7,7-dioxide
11/18/1997US5688965 Bactericides
11/18/1997US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
11/18/1997US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997US5688956 Method for preparing N-methyl 2-(3-pyridyl) (1R,2R)-2-tetrahydrothiopyrancarbothioamide-1-oxide
11/18/1997US5688955 Analgesics
11/18/1997US5688954 Process for the preparation of substituted thiopyran-1-oxides
11/18/1997US5688952 Vasoconstrictor intermediates
11/18/1997US5688950 Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
11/18/1997US5688949 Pyrazolo 1,5-A!pyrimidine derivatives and anti-inflammatory agent containing the same
11/18/1997US5688947 Production of purines via reductive formylation
11/18/1997US5688946 Amino acid derivatives having renin inhibiting activity
11/18/1997US5688945 Compounds
11/18/1997US5688943 Cholecystokinin antagonist; antiulcer agents; psychological drugs; anxiolytic agents; controlling appetite
11/18/1997US5688942 Process for preparing 2-isocephem derivatives
11/18/1997US5688938 Calcium receptor-active molecules
11/18/1997US5688926 Process of preparing etoposide phosphate and etoposide
11/18/1997US5688925 Glycosylation or etherification as antitumor agents
11/18/1997US5688924 Derivatives of 12,13-Epoxy-tylosin and processes of manufacture thereof
11/18/1997US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis
11/18/1997US5688829 Mixture containing dimethylacetamide, benzyl benzoate and ethyl oleate
11/18/1997US5688828 Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
11/18/1997US5688825 Sulfonyloxysuccimides
11/18/1997US5688824 Use of leflunomide to prevent or control xenograft rejection
11/18/1997US5688823 Thiazolidine and oxazolidine derivatives their preparation and their medical use
11/18/1997US5688820 Nervous system disorders; psychological disorders
11/18/1997US5688819 Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/18/1997US5688818 Enzyme inhibitors
11/18/1997US5688817 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics
11/18/1997US5688815 Hydroxypyridinones
11/18/1997US5688814 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/18/1997US5688813 2-phenyl-3-aroylbenzothiophenes
11/18/1997US5688812 Method of inhibiting seborrhea and acne
11/18/1997US5688811 Psychological disorders; nervous system disorders
11/18/1997US5688809 5-heteroarylindole derivatives
11/18/1997US5688807 Method for treating 5HT2B receptor related conditions
11/18/1997US5688806 Antiinflammatory agents and central nervous system disorders
11/18/1997US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen
11/18/1997US5688804 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists
11/18/1997US5688803 Tricyclic dicarbonyl derivatives
11/18/1997US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia
11/18/1997US5688801 Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
11/18/1997US5688799 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives
11/18/1997US5688798 Psychotic illness such as schizophrenia
11/18/1997US5688797 Treatment of acute central nervous system injury with piperazine derivatives
11/18/1997US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods
11/18/1997US5688795 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
11/18/1997US5688794 Administering metoclopramide
11/18/1997US5688793 Pyridazino 4',5':3,4!pyrrolo- 2,1-a!-isoquinolines and the use thereof for preparing pharmaceutical preparations
11/18/1997US5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent
11/18/1997US5688790 Phenylpyrrole derivatives and their use as antipsychotic agents
11/18/1997US5688789 PCP receptor ligands and the use thereof
11/18/1997US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof
11/18/1997US5688784 Method of suppressing appetite with vanadium complexes
11/18/1997US5688782 Medicaments for treating respiratory disorders
11/18/1997US5688781 Corticosteroids and antiinflammatory agents
11/18/1997US5688780 Anticholesterol agents, cholesterol biosynthesis inhibition
11/18/1997US5688773 Method of selectively destroying neoplastic cells
11/18/1997US5688772 Quinoa saponin compositions and methods of use
11/18/1997US5688771 Lipophilic oligopeptides with immunomodulating activity
11/18/1997US5688765 Dry eyes
11/18/1997US5688688 Vector for expression of a polypeptide in a mammalian cell
11/18/1997US5688654 GABA a receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to GABAa receptor subtypes
11/18/1997US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents
11/18/1997US5688528 Oil-in water emulsions
11/18/1997US5688524 Transdermal formulations for administering prazosin
11/18/1997US5688523 Method of making a pressure sensitive skin adhesive sheet material
11/18/1997US5688522 Ointment for wound treatment
11/18/1997US5688521 Lactulose pastilles
11/18/1997US5688520 Transmucosal delivery of melatonin for prevention of migraine